Cost-utility analysis of loxenatide versus DPP-4 inhibitors in Chinese patients with type 2 diabetes at high cardiovascular risk. [PDF]
Lai L +8 more
europepmc +1 more source
Integrating Disease Burden and Cost-Effectiveness for Value-Based Prioritisation of COPD Interventions: A Narrative Review. [PDF]
Zhang R, Yang L, Jing D, Chen L.
europepmc +1 more source
Migraine Prevalence and QALY Loss in Serbia: A Population-Level Stratified Modeling Study. [PDF]
Pasovski V +5 more
europepmc +1 more source
A Cost-Effectiveness Analysis for Treatments of Patients with Early Stage Huntington's Disease in the USA. [PDF]
Patil D +3 more
europepmc +1 more source
Cost-utility analysis of pre-exposure prophylaxis rabies vaccine in 5-year-old children in Thailand. [PDF]
Soopairin S +5 more
europepmc +1 more source
Cost-utility of NeuroSAFE-guided RARP Versus Standard RARP in Men with Localised Prostate Cancer in the UK. [PDF]
Wang J +10 more
europepmc +1 more source
Survival and quality-adjusted life years in critically ill cancer patients: analysis on the fifth day of intensive care unit stay. [PDF]
Machado MCV +3 more
europepmc +1 more source
A Cardiovascular Care Pathway Supported by Remote Patient Management in Dutch Primary Care: Cost-Effectiveness, Budget Impact, and Workload Analysis. [PDF]
Heijdra Suasnabar J +9 more
europepmc +1 more source
Costs and health burden of surgical site infections and anastomotic leakage in major abdominal surgery. [PDF]
Bontekoning N +8 more
europepmc +1 more source

